Procter & Gamble vs. Colgate-Palmolive: Which Dividend Stock Is Safer?
Procter & Gamble (PG) and Colgate-Palmolive (CL) both beat earnings expectations. PG reported Q1 FY2027 core EPS of $2.00, with organic sales up 4.0%, driven by volume. CL beat with EPS of $0.97, with organic growth of 3.6%, driven by pricing. PG's dividend yield is 2.6%, while CL's is 2.1%. PG's cash flow comfortably covers its dividend, while CL's equity has thinned due to repurchases. CL shares are up 29.3% YTD, versus 21.33% for PG.
How this was made
The 30-second read
Why it matters
Provides fresh earnings numbers and dividend coverage metrics, enabling traders to reassess relative valuation and risk.
Market read
First‑report earnings for both PG and CL give fresh data for dividend‑oriented strategies and sector positioning.
What to watch
Potential impact of oil price volatility on P&G's commodity costs and the effect of emerging‑market currency swings on Colgate's cash flow.
Background
The article compares two large‑cap dividend stocks in the consumer staples sector, focusing on recent earnings, cash‑flow coverage, and dividend safety for retirees.
Ticker impact
Procter & Gamble reported Q1 FY2027 EPS of $2.00 beating estimates, with strong volume growth and a dividend that remains well covered by cash flow.
likely modest upside as market prices in the earnings beat while monitoring commodity cost headwinds
Beat on earnings and volume indicates strength; margin compression suggests limited upside.
Colgate-Palmolive posted Q1 FY2027 EPS of $0.97 beating estimates, with margin expansion but a 3.7% volume decline in North America and a thinner cash buffer.
potential pressure as investors weigh volume decline against earnings beat
Mixed signals: earnings beat vs. volume drop and limited cash coverage of dividend.
Market effects
Both consumer staples peers may see increased scrutiny on dividend sustainability amid commodity cost pressures.
U.S. consumer‑goods sector may experience modest re‑rating as investors compare dividend safety.
Highlights broader concerns about inflation‑driven cost spikes for dividend‑focused investors worldwide.
Counterpoint
Investors could favor Colgate if its margin expansion outpaces P&G's cost headwinds, betting on a turnaround in North America volume.
Key entities
- CompanyProcter & Gamble
Consumer goods giant with strong earnings beat and dividend coverage.
- CompanyColgate-Palmolive
Oral‑care specialist with earnings beat but weaker cash‑flow buffer.
